IGF1 and embryonal carcinoma: In the murine embryonal carcinoma-derived cell line ATDC5, TrkB inhibition with either K252a or AG879 dramatically blocks chondrocyte differentiation as measured by Col2a1 and ColX expression, but does not alter IGF-I-stimulated proliferation (4).